文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

利用口腔微生物组相关抗生素耐药基因的基因组特征诊断胰腺癌。

Leveraging genomic signatures of oral microbiome-associated antibiotic resistance genes for diagnosing pancreatic cancer.

机构信息

Qingdao municipal hospital(group) Stomatology, Qingdao, Shandong, China.

Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China.

出版信息

PLoS One. 2024 Apr 30;19(4):e0302361. doi: 10.1371/journal.pone.0302361. eCollection 2024.


DOI:10.1371/journal.pone.0302361
PMID:38687802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11060577/
Abstract

Growing evidence has increasingly suggested a potential linkage between the oral microbiome and various diseases, including pancreatic ductal adenocarcinoma (PDAC). However, the utilization of gene-level information derived from the oral microbiome for diagnosing PDAC remains unexplored. In this study, we sought to investigate the novel potential of leveraging genomic signatures associated with antibiotic resistance genes (ARGs) within the oral microbiome for the diagnosis of PDAC. By conducting an analysis of oral microbiome samples obtained from PDAC patients, we successfully identified specific ARGs that displayed distinct sequence abundance profiles correlated with the presence of PDAC. In the healthy group, three ARGs were found to be enriched, whereas 21 ARGs were enriched in PDAC patients. Remarkably, these ARGs from oral microbiome exhibited promising diagnostic capabilities for PDAC (AUROC = 0.79), providing a non-invasive and early detection method. Our findings not only provide novel modal data for diagnosing PDAC but also shed light on the intricate interplay between the oral microbiome and PDAC.

摘要

越来越多的证据表明,口腔微生物组与各种疾病之间存在潜在联系,包括胰腺导管腺癌(PDAC)。然而,利用口腔微生物组中源自基因水平的信息来诊断 PDAC 仍未得到探索。在这项研究中,我们试图研究利用口腔微生物组中与抗生素耐药基因(ARGs)相关的基因组特征来诊断 PDAC 的新潜力。通过对来自 PDAC 患者的口腔微生物组样本进行分析,我们成功鉴定出了与 PDAC 存在相关的具有独特序列丰度特征的特定 ARGs。在健康组中,发现有三个 ARGs 富集,而在 PDAC 患者中则有 21 个 ARGs 富集。值得注意的是,这些来自口腔微生物组的 ARGs 对 PDAC 具有有前景的诊断能力(AUROC=0.79),提供了一种非侵入性和早期检测方法。我们的研究结果不仅为诊断 PDAC 提供了新的模态数据,还揭示了口腔微生物组与 PDAC 之间复杂的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce70/11060577/599babbd69fc/pone.0302361.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce70/11060577/62e2fb24bf90/pone.0302361.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce70/11060577/49d904b459e2/pone.0302361.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce70/11060577/a1bf2dda382e/pone.0302361.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce70/11060577/599babbd69fc/pone.0302361.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce70/11060577/62e2fb24bf90/pone.0302361.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce70/11060577/49d904b459e2/pone.0302361.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce70/11060577/a1bf2dda382e/pone.0302361.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce70/11060577/599babbd69fc/pone.0302361.g004.jpg

相似文献

[1]
Leveraging genomic signatures of oral microbiome-associated antibiotic resistance genes for diagnosing pancreatic cancer.

PLoS One. 2024

[2]
Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis.

Biomol Biomed. 2023-12-28

[3]
Alterations of the bile microbiome is associated with progression-free survival in pancreatic ductal adenocarcinoma patients.

BMC Microbiol. 2024-7-1

[4]
The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study.

Cancer Causes Control. 2017-9

[5]
Deciphering the pancreatic cancer microbiome in Mainland China: Impact of Exiguobacterium/Bacillus ratio on tumor progression and prognostic significance.

Pharmacol Res. 2024-6

[6]
A faecal microbiota signature with high specificity for pancreatic cancer.

Gut. 2022-7

[7]
Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review).

Int J Oncol. 2021-12

[8]
Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.

Carcinogenesis. 2020-7-10

[9]
Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: a pilot study.

Sci Rep. 2022-1-7

[10]
Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma.

Pancreatology. 2023-9

本文引用的文献

[1]
Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis.

Biomol Biomed. 2023-12-28

[2]
Cross-cohort single-nucleotide-variant profiling of gut microbiota suggests a novel gut-health assessment approach.

mSystems. 2023-12-21

[3]
Resistome expansion in disease-associated human gut microbiomes.

Microbiome. 2023-7-29

[4]
The oral microbiota is a reservoir for antimicrobial resistance: resistome and phenotypic resistance characteristics of oral biofilm in health, caries, and periodontitis.

Ann Clin Microbiol Antimicrob. 2023-5-13

[5]
Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy.

JAMA Netw Open. 2023-3-1

[6]
Development of the oral resistome during the first decade of life.

Nat Commun. 2023-3-9

[7]
Latent antibiotic resistance genes are abundant, diverse, and mobile in human, animal, and environmental microbiomes.

Microbiome. 2023-3-8

[8]
Metagenomic analysis examines oral microbiome changes and interplay with immune response following prenatal total oral rehabilitation.

J Transl Med. 2023-3-4

[9]
Oral mycobiota and pancreatic ductal adenocarcinoma.

BMC Cancer. 2022-12-2

[10]
Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study.

Gastroenterology. 2022-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索